May. 12, 2017Topics
Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for regulators.
Apr. 25, 2017News & Opinions
Pharma chiefs are urging European heads of state to decide sooner rather than later on the new location for the European Medicines Agency (EMA), which is due to leave the UK as a result of Brexit.
Nov. 23, 2016News & Opinions
Two former private investigators, the British-Chinese husband and wife team of Peter Humphrey and Yu Yingzeng, have filed suit against GlaxoSmithKline (GSK) in a US district court. They claim the UK’s largest drugmaker hired them in ...
Nov. 10, 2016News & Opinions
Shares in major globally active pharmaceutical producers rose by as much as 11% on the news that Donald Trump had won the Nov. 8 election as president of the United States. The trade journal FirstWord Pharma said the increases—led by ...
Jul. 28, 2016News & Opinions
In a post-Brexit vote of confidence, major drugmaker Glaxo SmithKline (GSK) has announced it will invest £275 million in its UK network to boost production and support delivery of its respiratory and large molecule biological drugs. ...
Jul. 15, 2016Topics
As the reality, and increasingly the finality, of Britain’s June 23 vote to leave the European Union began to sink in, chemical and pharmaceutical producers across the country in mid-July began to prepare for doing business ...
Jun. 17, 2016News & Opinions
GlaxoSmithKline’s head of vaccines, Moncef Slaoui, has announced he will leave the company in June 2017 after nearly three decades at the company. Since joining GSK in 1998, Slaoui has served in a number of positions, including ...
May. 18, 2016News & Opinions
A break-up of the UK’s largest pharmaceutical company, GlaxoSmithKline (GSK) is not under consideration at the moment, GSK Chairman Phillip Hampton told the company’s annual general meeting on May 5, according to the news ...
Mar. 01, 2016News & Opinions
British drugmaker GlaxoSmithKline is said to have launched a search for a new CEO to replace Andrew Witty, who is now widely expected to step down at the latest by the end of 2017.
Feb. 15, 2016News & Opinions
Major UK drugs firm GlaxoSmithKline (GSK) has been fined more than £37 million by the Competition and Markets Authority (CMA) for anti-competitive behavior relating to generic forms of its anti-depressant Seroxat.
The latest information directly via newsletter.